Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. In 2023, the company finalized ...

Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...

Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an eight-week period.

In the latest trading session, Amgen (AMGN) closed at $294.76, marking a -1.17% move from the previous day. This change lagged the S&P 500's daily loss of 0.01%. Elsewhere, the Dow lost 0.32%, while ...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of ...

Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...

This was the stock's second consecutive day of losses.

Every ~20 seconds in the U.S a woman aged 50 or older suffers a fracture.1 These fractures result in higher rates of hospitalization than heart attack, stroke, or breast cancer, while having ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

Shares of Johnson & Johnson and Amgen are trading higher Wednesday afternoon, propelling the Dow Jones Industrial Average into positive territory.

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

The idea for Amgen’s first foray into documentary film started with two numbers, according to Nerissa Gomes, general manager ...